Burkitt lymphoma with a granulomatous reaction: an M1/ Th1-polarised microenvironment is associated with controlled growth and spontaneous regression lymphoma with a granulomatous reaction: an M1/Th1-polarised microenvironment is associated with controlled growth and spontaneous regression

Massimo Granai, Stefano Lazzi, Virginia Mancini, Ayse Akarca, Raffaella Santi, Federica Vergoni, Ester Sorrentino, Raffaella Guazzo, Lucia Mundo, Gabriele Cevenini, Claudio Tripodo, Gioia Di Stefano, Benedetta Puccini, Maurilio Ponzoni, Elena Sabattini, Claudio Agostinelli, Nuray Bass€ ull€ u, T€ ulay Tecimer, Ahu Senem Demiroz, Leah Mnango, Stephan Dirnhofer, Leticia Quintanilla-Martinez, Teresa Marafioti, Falko Fend & Lorenzo Leoncini Department of Medical Biotechnologies, University of Siena, Siena, Italy, Institute of Pathology, University of T€ ubingen, T€ ubingen, Germany, Department of Cellular Pathology, University College London, London, UK, Department of Pathology, University of Florence, Florence, Italy, Health Research Institute, University of Limerick, Limerick, Ireland, Department of Human Pathology, University of Palermo, Palermo, Department of Haematology, University of Florence, Florence, Department of Pathology, University Vita-Salute San Raffaele, Milano, Haemolymphopathology Unit IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy, Department of Pathology, Bilim University, _ Istanbul, Department of Pathology, Acibadem University, _ Istanbul, Department of Pathology, _ Istanbul University Cerrahpas a, _ Istanbul, Turkey, Department of Pathology, Muhimbili National Hospital and University for Healthcare and Allied Sciences, Dar-es-Salaam, Tanzania, and Institute of Pathology, University Hospital Basel, Basel, Switzerland

[1]  A. Akarca,et al.  Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program , 2020, Infectious Agents and Cancer.

[2]  K. Naresh,et al.  Role of Epstein-Barr virus in transformation of follicular lymphoma to diffuse large B-cell lymphoma: a case report and review of the literature , 2019, Haematologica.

[3]  V. Ranzani,et al.  Eomesodermin controls a unique differentiation program in human IL‐10 and IFN‐γ coproducing regulatory T cells , 2018, European journal of immunology.

[4]  J. T. Afshari,et al.  Macrophage plasticity, polarization, and function in health and disease , 2018, Journal of cellular physiology.

[5]  A. Rosenwald,et al.  The clinicopathologic spectrum of mature aggressive B cell lymphomas , 2017, Virchows Archiv.

[6]  V. A. Stewart,et al.  Regulatory T Cells in Endemic Burkitt Lymphoma Patients Are Associated with Poor Outcomes: A Prospective, Longitudinal Study , 2016, PloS one.

[7]  David C Park,et al.  Novel insights into the early histopathogenesis of immunodeficiency‐associated Burkitt lymphoma: a case report of Burkitt microlymphoma arising within HIV lymphadenitis , 2016, Histopathology.

[8]  Burton E. Barnett,et al.  Cutting Edge: B Cell–Intrinsic T-bet Expression Is Required To Control Chronic Viral Infection , 2016, The Journal of Immunology.

[9]  P. Piccaluga,et al.  The cell of origin of Burkitt lymphoma: germinal centre or not germinal centre? , 2016, Histopathology.

[10]  S. Pileri,et al.  Clonality Analysis of Immunoglobulin Gene Rearrangement by Next-Generation Sequencing in Endemic Burkitt Lymphoma Suggests Antigen Drive Activation of BCR as Opposed to Sporadic Burkitt Lymphoma , 2015, American journal of clinical pathology.

[11]  S. Pileri,et al.  Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma , 2015, PLoS pathogens.

[12]  M. Nussenzweig,et al.  Plasmodium Infection Promotes Genomic Instability and AID-Dependent B Cell Lymphoma , 2015, Cell.

[13]  M. Meyerson,et al.  The tumor virus landscape of AIDS-related lymphomas. , 2015, Blood.

[14]  H. Einsele,et al.  Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT. , 2015, Blood.

[15]  Hongwei Liang,et al.  Molecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance , 2014, Front. Immunol..

[16]  Wenyan Zhang,et al.  HIV-related Burkitt lymphoma with florid granulomatous reaction: an unusual case with good outcome. , 2014, International journal of clinical and experimental pathology.

[17]  Yong-ming Yao,et al.  Macrophage Polarization in Inflammatory Diseases , 2014, International journal of biological sciences.

[18]  B. Kempkes,et al.  Macrophage Polarisation: an Immunohistochemical Approach for Identifying M1 and M2 Macrophages , 2013, PloS one.

[19]  T. Decker,et al.  The regulation of inflammation by interferons and their STATs , 2013, JAK-STAT.

[20]  E. Vigorito,et al.  Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma , 2012, Blood Cancer Journal.

[21]  Graham M. Lord,et al.  T-bet and GATA3 orchestrate Th1 and Th2 differentiation through lineage-specific targeting of distal regulatory elements , 2012, Nature Communications.

[22]  A. Rosato,et al.  The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders , 2010, Haematologica.

[23]  Lionel B Ivashkiv,et al.  Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. , 2009, Immunity.

[24]  H. Zebroski,et al.  Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers. , 2007, Blood.

[25]  B. Walker,et al.  Differential targeting and shifts in the immunodominance of Epstein-Barr virus--specific CD8 and CD4 T cell responses during acute and persistent infection. , 2005, The Journal of infectious diseases.

[26]  S. Pileri,et al.  Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. , 2005, Blood.

[27]  E. Jaffe,et al.  Granulomatous reaction in Burkitt lymphoma: correlation with EBV positivity and clinical outcome. , 2005, The American journal of surgical pathology.

[28]  C. Münz Epstein-Barr Virus Nuclear Antigen 1 , 2004, The Journal of experimental medicine.

[29]  E. Haralambieva,et al.  Florid Granulomatous Reaction in Epstein-Barr Virus-positive Nonendemic Burkitt Lymphomas: Report of Four Cases , 2004, The American journal of surgical pathology.

[30]  R. Fåhraeus,et al.  Self-Inhibition of Synthesis and Antigen Presentation by Epstein-Barr Virus-Encoded EBNA1 , 2003, Science.

[31]  P. Kidd Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. , 2003, Alternative medicine review : a journal of clinical therapeutic.

[32]  S. Stevanović,et al.  Epstein-Barr Nuclear Antigen 1-Specific CD4+ Th1 Cells Kill Burkitt’s Lymphoma Cells1 , 2002, The Journal of Immunology.

[33]  E. Bloemena,et al.  Differential Immunogenicity of Epstein-Barr Virus Latent-Cycle Proteins for Human CD4+ T-Helper 1 Responses , 2001, Journal of Virology.

[34]  Kristi Kincaid,et al.  M-1/M-2 Macrophages and the Th1/Th2 Paradigm1 , 2000, The Journal of Immunology.

[35]  R. Steinman,et al.  Human Cd4+ T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1 , 2000, The Journal of experimental medicine.

[36]  T. Langmann,et al.  Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro‐ and antiinflammatory stimuli , 2000, Journal of leukocyte biology.

[37]  L. Frappier,et al.  Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing. , 1997, Immunity.

[38]  P. Cresswell,et al.  Class I processing-defective Burkitt's lymphoma cells are recognized efficiently by CD4+ EBV-specific CTLs. , 1997, Journal of immunology.

[39]  E. Jaffe,et al.  Small Noncleaved Cell Lymphoma Associated with Florid Epithelioid Granulomatous Response: A Clinicopathologic Study of Seven Patients , 1993, The American journal of surgical pathology.

[40]  B. Nathwani,et al.  Hodgkin's disease occurring in monocytoid B-cell clusters. , 1991, American journal of clinical pathology.

[41]  Keith E Steele,et al.  Multiplex Immunohistochemistry for Image Analysis of Tertiary Lymphoid Structures in Cancer. , 2018, Methods in molecular biology.

[42]  P. Babál,et al.  Burkitt lymphoma with unusual granulomatous reaction. A case report. , 2011, Ceskoslovenska patologie.

[43]  H. Stein,et al.  T-bet-positive and IRTA1-positive monocytoid B cells differ from marginal zone B cells and epithelial-associated B cells in their antigen profile and topographical distribution. , 2005, Haematologica.

[44]  M. Hansmann,et al.  Monocytoid B-cells occurring in Hodgkin's disease , 2004, Virchows Archiv.

[45]  R. Steinman,et al.  EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function. , 2001, The Journal of clinical investigation.